search
California firm
Trends
- 1California firm licenses anti-measles antibodies from Vanderbilt▼California firm licenses ‘potent’ anti-measles antibodies from Vanderbilt Health for development, clinical testing
A California company has licensed potent anti-measles antibodies from Vanderbilt Health to develop them for clinical testing. The agreement moves laboratory research on measles-fighting antibodies toward potential treatments, at a time when measles cases have been resurging in parts of the United States and abroad and health officials are pressing for stronger tools to prevent and treat outbreaks.
- 2California Weighs Emergency Rules on Private Equity in Health Care●Comment Period Closes on California OHCA’s Proposed Emergency Regulations Expanding Private Equity, Hedge Fund, and MSO Reporting in Health Care Transactions
California's Office of Health Care Affordability has closed the comment period on proposed emergency regulations that would expand reporting requirements for health care transactions involving private equity firms, hedge funds, and management services organizations. The rules would give regulators broader visibility into deal activity across the state's health care market. Commenters now await the agency's response before the regulations move forward.
- 3HGGC: Palo Alto Private Equity Firm Focused on Middle-Market Tech▼HGGC: Palo Alto private equity firm investing in middle-market technology and services companies
HGGC is a private equity firm based in Palo Alto, California, that invests in middle-market companies, with a particular focus on technology and services businesses. The firm pursues buyouts and growth investments in mid-sized companies across these sectors, positioning itself as an active investor in the middle-market technology and services space.